Cochrane Abstracts
Phosphodiesterase 5 inhibitors for pulmonary hypertension
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Phosphodiesterase 5 Inhibitors for Pulmonary Hypertension." Cochrane Abstracts, John Wiley & Sons, Inc, 2026. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/434997/all/Phosphodiesterase_5_inhibitors_for_pulmonary_hypertension.
Phosphodiesterase 5 inhibitors for pulmonary hypertension. Cochrane Abstracts. John Wiley & Sons, Inc; 2026. https://evidence.unboundmedicine.com/evidence/view/Cochrane/434997/all/Phosphodiesterase_5_inhibitors_for_pulmonary_hypertension. Accessed April 21, 2026.
Phosphodiesterase 5 inhibitors for pulmonary hypertension. (2026). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/434997/all/Phosphodiesterase_5_inhibitors_for_pulmonary_hypertension
Phosphodiesterase 5 Inhibitors for Pulmonary Hypertension [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2026. [cited 2026 April 21]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/434997/all/Phosphodiesterase_5_inhibitors_for_pulmonary_hypertension.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Phosphodiesterase 5 inhibitors for pulmonary hypertension
ID - 434997
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/434997/all/Phosphodiesterase_5_inhibitors_for_pulmonary_hypertension
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
